drugset / Trial / NCT05728333

Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke

NCT05728333

RandomizedParallel-groupDouble-blindTreatment

Summary

In patients with acute ischemic stroke secondary to large vessel occlusion, the role of intravenous adjunctive medications, such as tirofiban, or alteplase before endovascular thrombectomy has not been well investigated. This trial aim to evaluate the efficacy and safety of intravenous tirofiban versus alteplase for acute ischemic stroke patients with large vessel occlusion piror to endovascular thrombectomy.

Timeline

Start
2023-11-28
Primary completion
2026-02-28
Completion
2026-07-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alteplase Protein / enzyme biologic Intravenous
Subject Tirofiban Other / unclassified Intravenous

Indications